fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

ESMO 2014 Report: Special symposium on ‘Advances in precision medicine of metastatic colorectal cancer’

Written by | 21 Nov 2014

by Denys Wheatley: There is some irony in the title of this symposium because medicine should always be as precise as it can, and advances are expected that… read more.

No harm in yoga: But not much help for asthma sufferers

Written by | 21 Aug 2014

Researchers examine health benefits of yoga for asthma sufferers. Yoga has long been promoted as a method for improving physical and mental well-being. And although yoga is often… read more.

ILTS 2014: Liver-directed cellular therapy – hope or hype?

Written by | 7 Aug 2014

Feature Symposium.  Stephen Strom, Karolinska Institutet, Stockholm, Sweden.   Luc van der Laan, Erasmus Medical Center, Rotterdam, the Netherlands.  Alberto Sanchez-Fueyo, King’s College Hospital, London, UK.  David Hay, University… read more.

Reducing ‘cytokine storm’ in flu victims

Written by | 8 Jul 2014

World Health Matters: Australia by Gary Finnegan – Highly virulent forms of the influenza virus can cause serious illness and may be fatal. Some of the damage is… read more.

Cell therapy shows ability to fight cancer

Written by | 19 Feb 2014

Genetically modified T cells induced complete remissions in 88 percent of advanced leukemia patients treated.  Investigators have reported more encouraging news about one of the most exciting methods… read more.

Novel agent shows promise for non-small cell lung cancer

Written by | 3 Dec 2013

by Bruce Sylvester – Researchers report that an experimental cancer drug which has shown efficacy in  treating melanoma also shows promise  in treating non-small cell lung cancer, a… read more.

ESMO WCGC 2013 Report – Hot topics in Colon Cancer

Written by | 12 Sep 2013

by Pam Harrison – MSI status has clear prognostic value in stage II CRC Julien Taieb, MD, PhD, University of Paris Descartes, Paris, France Microsatellite instability (MSI), a… read more.

ASCO 2013 – Important advances in treatment for multiple aggressive cancers, and new insight on HPV-related cancer risk

Written by | 20 Jun 2013

CHICAGO – New advances against melanoma, ovarian cancer, and colorectal cancer care were presented today at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)…. read more.

ASCO 2013 Report – Drugs combo therapy leads to dramatic tumor shrinkage in advanced melanoma patients

Written by | 11 Jun 2013

by Bruce Sylvester – More than half of patients with metastatic melanoma treated with the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab have achieved durable tumor… read more.

ASCO 2013 Report – Lambrolizumab immunotherapy shows efficacy in advanced melanoma

Written by | 10 Jun 2013

Researchers report that investigative lambrolizumab has shown promising results, in advanced melanoma, with manageable side effects.

ASCO 2013 Report – Sorafenib shows efficacy in advanced differentiated thyroid cancer

Written by | 10 Jun 2013

by Bruce Sylvester – over 30,000 clinicians and researchers attended the American Society of Clinical Oncology 2013 annual meeting in Chicago on May 31-June 4. Among the most… read more.

Older and younger chronic leukemia patients may need different therapy

Written by | 5 Jun 2013

Doctors should use different therapies when treating older and younger patients with chronic lymphocytic leukemia, according to a new study.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.